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Profiling of peritoneal ultrafiltration
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The historical course of peritoneal dialysis can be char- OVERVIEW OF ULTRAFILTRATION
acterized by successive phases of development: the first PHYSIOLOGY
phase after the introduction of continuous ambulatory It is important at the outset to review the balance of
peritoneal dialysis (CAPD) was focused on establishing opposing forces governing peritoneal ultrafiltration in
the therapy, addressing pressing technological needs in PD. These can be readily illustrated from the early work
connectology and introduction of automation [1–8]. The of Mactier et al [17] represented in Figure 1. They evalu-
second phase tackled controversial issues and ultimately ated ultrafiltration (UF) kinetics observed with the use
led to the resolution of two contentious aspects: the vindi- of 2.5% dextrose solution in CAPD patients with normal
and high peritoneal transport patterns. The changes incation of peritoneal dialysis as a long-term therapy with
intraperitoneal volume are characterized by a biphasicpatient outcomes equivalent to those of hemodialysis
behavior: in the initial phase this is dominated by trans-[9–12], and the proper determination of the relative im-
capillary ultrafiltration, which is driven principally by theportance of small solute clearance by a definitive ran-
crystalloid osmotic gradient generated by glucose but isdomized controlled trial [13] and cumulative observa-
governed also by the relatively constant hydrostatic andtional explorations [reviewed in 13]. The present third
oncotic pressure gradients (the so-called ‘Starling forces’)phase of the history of the therapy can be defined as
[18]. As transcapillary ultrafiltration rate exceeds lym-that of focus on fluid balance and cardiovascular out-
phatic and tissue absorption, intraperitoneal volume in-comes. This phase was heralded by the landmark work
creases [17]. The decline in glucose concentration, how-of the International Society of Peritoneal Dialysis ad hoc
ever, occurs precipitously resulting in a decrease in theCommittee of Ultrafiltration Management in Peritoneal
transcapillary ultrafiltration rate. As long as transcapil-Dialysis [14, 15], which corrected the critical absence
lary ultrafiltration exceeds lymphatic absorption, the
of fluid management issues from dialysis management
peritoneum is operating under a fluid transport disequi-
guidelines issued by various committees [16]. The work librium favoring positive net ultrafiltration. When the
of the committee highlighted not only the importance transcapillary ultrafiltration rate declines to a value equal
of the issue of fluid management, but also the limitations to the lymphatic flow rate, a state of equilibrium in fluid
inherent in diagnostic evaluations of peritoneal ultrafil- transport obtains and no increase in intraperitoneal vol-
tration [15]. One of the critical recommendations of the ume occurs. This is the point at which peak intraperito-
committee was the adoption of a variant of the peritoneal neal volume is reached. Peak UF volume is observed
equilibration test (PET) utilizing a higher glucose con- before osmotic equilibrium between serum and dialysate
centration (4.25% dextrose/3.86% glucose) for the evalu- is reached and occurs when the rate of net transcapillary
ation of ultrafiltration failure [15]. This was based on the UF slows to equal that of lymphatic reabsorption [17].
recognition of the inadequacy of the standard 2.5/2.27% Thereafter, the rate of lymphatic reabsorption exceeds
test to discriminate between true ultrafiltration failure that for net transcapillary UF, resulting in reduced intra-
and normal inter-individual variations. The aim of the peritoneal volume.
present article is to pursue further the evaluation of The difference between the declining transcapillary
the value of the standard PET in profiling peritoneal ultrafiltration rate and the constant lymphatic tissue ab-
sorption eventually leads to a new state of fluid transportultrafiltration, and to offer a profiling model based on
disequilibrium dominated by net fluid absorption andmore extensive clinical data and mathematical modeling.
negative net ultrafiltration. This characterizes the second
and final phase of changes in intraperitoneal volume: a
linear and steady decline [17, 18].Key words: renal replacement therapy, CAPD, automated peritoneal
dialysis, small solute clearance, fluid management, PET. The net clinical effect of the operation of these oppos-
ing forces governing peritoneal fluid movement depends 2002 by the International Society of Nephrology
S-17
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Fig. 1. Time profiles of opposing forces governing ultrafiltration (trans-
Fig. 2. Proportional distribution of patients in the standard transportcapillary ultrafiltration and lymphatic absorption). Symbols are: ()
categories by PET. Data are from 1229 patients.absorption; () transcapillary UF; () net UF. The net effect of these
two processes is represented as net UF. Redrawn from Mactier et al
[17]; used with permission of the Journal of Clinical Investigation.
[38]. The distribution of patients in the various subsets
are shown in Figure 2 and Table 1, where the original
on the time at which the peritoneal cavity is drained. If approach of Twardowski in dividing the population into
drainage is delayed until late in the final phase, the vol- groups based on inclusion within and without one stan-
ume drained may approach or even be less than the dard deviation from the mean was followed [38]. As the
volume instilled. In high transporters, Mactier et al found population deviates slightly from a normal distribution
that lymphatic drainage caused a proportionately greater pattern, the low average and high average groups are
reduction in net UF due to quicker absorption of dialy- not proportionally equal.
sate glucose and significantly less cumulative transcapil- Peritoneal equilibrium test categories are usually as-
lary UF [17]. Patients who are high and high average signed based on D/P creatinine at four hours. We exam-
transporters are more vulnerable to manifesting negative ined the degree of concordance between this categoriza-
net ultrafiltration because of the lower peak intraperito- tion approach and that based on the four-hour D/D0 forneal volume achieved. This vulnerability is directly re-
glucose. There was a correlation between the D/P cre-
lated to the duration of the dwell and tends to become
atinine and the D/D0 glucose (r  0.736, P  0.0001),commonly manifest in the long nighttime dwell of contin-
though the concordance for classifying a particular pa-
uous ambulatory peritoneal dialysis (CAPD) or daytime
tient was only about 60%, as shown in Table 1. The de-dwell in automated peritoneal dialysis (APD).
gree of concordance was similar across transport catego-
ries. Most discordant cases fell within a contiguous cate-
REVISITING THE PET gory. The D/P creatinine was not correlated with body
size, age, normalized protein nitrogen appearance rateThe peritoneal equilibrium test (PET) has been con-
(nPNA), urea generation, creatinine generation, residualsidered a cornerstone of peritoneal dialysis (PD) therapy
renal function or lymphatic flow, and none of these mea-management, and has been used to model prescriptions
sures was different between the different PET categories.[19–33]. Its success in this regard has been mainly in
We next examined the robustness of PET results inallowing prediction of small solute clearances [34–36].
predicting ultrafiltration (Table 2). In univariate analysis,Classifications of patient populations by PET results pro-
the best correlation with net ultrafiltration (UF) was foundfile have been previously done in moderately sized pa-
for four-hour D/D0 glucose. Various combinations oftient groups and much was made of differences between
multivariate analysis showed small improvement in thepopulations based on these studies [19–33, 37]. Varia-
correlation. Under the best conditions, however, the r2tions in the distribution of PET transport categories have
was small suggesting the serious limitations of transportbeen described, but appear to be minimal across disease
parameters observed during the standard PET to predictstates and ethnic origins when accounting for sample
net UF (Table 2). While a general trend of a decline insize, body size and use of standard techniques [19–33].
net ultrafiltration during a standard PET is observed fromBecause of the errors inherent in small sample size, we
the low transport to the high transport categories, a greatsought to examine the results of the test in a large popula-
degree of overlap is observed (Fig. 3). We reasoned thattion of 1229 peritoneal dialysis patients evaluated as part
the underlying cause for the high degree of overlap be-of a national adequacy initiative program (T.A.R.G.E.T;
tween the categories is due to the time at which the PETBaxter Healthcare Corporation, Deerfield, IL, USA).
is usually terminated and longer observations may yieldMean D/P creatinine was 0.67 and an SD of 0.12, values
very similar to the original description by Twardowski more consistent separations between the groups.
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Table 1. PET results in a large patient cohort
Transport category by D/P creatinine
Low Low average High average High
N 185 402 455 187
Percent 15.05 32.71 37.02 15.21
Concordance with D/D0 60.9% 63.9% 57.4% 60.9%
Age 51.71.0 54.10.7 56.80.6 53.81.1
BSA 1.840.02 1.880.01 1.910.01 1.880.02
Lymphatic flow 0.890.06 0.850.03 0.980.04 1.180.32
Net UF mL/4 h 45217 36611 32611 21617
Values are mean  SE.
Table 2. Correlates of ultrafiltration during a PET
Correlation
Variable(s) with net UF P value
2 hours D/D0 glucose 0.267 0.0001
4 hours D/D0 glucose 0.283 0.0001
2 & 4 hours D/D0 glucose 0.292 0.0001
2 hours D/P creatinine 0.271 0.0001
4 hours D/P creatinine 0.277 0.0001
2 & 4 hours D/P creatinine 0.286 0.0001
4 hours D/D0 glucose & 4 hours
D/P creatinine 0.301 0.0001
4 hours D/D0 glucose & 2 &
4 hours D/P creatinine 0.310 0.0001
2 & 4 hours D/D0 glucose & 2 &
4 hours D/P creatinine 0.311 0.0001
2 & 4 hours D/D0 glucose &
4 hours D/P creatinine 0.307 0.0001
Fig. 3. Ultrafiltration during the PET displayed by transport category
with mean and SD showing a very high degree of overlap between the
four categories. Abbreviations are: L, low transport; LA, low average
transport; HA, high average transport; H, high transport group.
ULTRAFILTRATION PROFILING
To better define the profiles of ultrafiltration beyond
the time limits of the standard PET, we simulated four- pore model parameters (for example, mass transfer area
teen-hour dwells based on the kinetic parameters of 396 coefficients, reflection coefficients, etc.) for these five
patients who participated in the initial phase of the “average” dextrins and models net ultrafiltration using
T.A.R.G.E.T. program. This subset of patients was these parameters in combination with default starting
chosen because they had complete PET and long-dwell blood concentrations at or below the levels reported by
data needed to estimate the kinetic parameters required Davies [39].
to model solute clearance and ultrafiltration. Based on In terms of kinetic parameters the 396 patients had:
these 396 patients, fourteen-hour ultrafiltration profiles an estimated UF coefficient of 0.0729  0.0361 mL/min/
for 1.50%, 2.50%, and 4.25% Dianeal and 7.50% Ex- mm Hg; an average fluid absorption rate of 1.1  0.7
traneal were computed using PD ADEQUEST 2.0. In mL/min (representing unmeasured Starling Forces and
order to model Extraneal, a polydispersed glucose poly- lymphatic flow); an average peritoneal surface area (A0/
mer preparation consisting of dextrins ranging in size dX) of 30,416  7653 cm2; and estimated small solute
from 2 to 1000 carbohydrate units, the molecular weight mass transfer area coefficients of 24.7  6.7 mL/min for
distribution of the dextrins was established using size urea, 12.4  3.9 mL/min for creatinine and 11.6  3.6
exclusion chromatography. This distribution can be sum- mL/min for glucose.
marized into five representative glucose polymer size Results of computer modeling characterizing the ultra-
classes (or subfractions). Based on a log-normal distribu- filtration (UF) potential of 1.5% dextrose by a peritoneal
tion, the average molecular weight and osmolarity were membrane transport pattern—low, low-average, high-
determined for each subfraction resulting in five “aver- average, and high—are presented in Figure 4. A biphasic
age” dextrins. PD ADEQUEST 2.0 then models ultrafil- response profile was evident in all transport category
tration assuming the entire icodextrin solution can be groups: an early increase in intraperitoneal volume fol-
adequately characterized by these five “average” dex- lowed by a terminal decline. The critical differentiating
features, however, were the greater divergence betweentrins. PD ADEQUEST 2.0 computes the necessary three-
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Fig. 4. Temporal profile of net ultrafiltration in the four standard trans- Fig. 6. Temporal profile of net ultrafiltration in the four standard trans-
port categories with the use of 1.5% dextrose solution. Symbols are: port categories with the use of 4.25% dextrose solution. Symbols are:
() low transport; () low average transport; () high average trans- () low transport; () low average transport; () high average trans-
port; () high transport group. port; () high transport group.
Fig. 5. Temporal profile of net ultrafiltration in the four standard trans- Fig. 7. Temporal profile of net ultrafiltration in the four standard trans-
port categories with the use of 2.5% dextrose solution. Symbols are: port categories with the use of 7.5% icodextrin solution. Symbols are:
() low transport; () low average transport; () high average trans- () low transport; () low average transport; () high average trans-
port; () high transport group. port; () high transport group.
corresponding to the long dwell in CAPD and APD.the curves representing the four transport categories and
the different times after instillation at which the lines These observations are consistent with the clinical obser-
vations of high negative net UF in these types of patientscrossed zero, indicating the occurrence of negative net
ultrafiltration. In general, patients with high or high- during the long dwell with 2.5% dextrose (abstract; Wolf-
son et al; J Am Soc Nephrol 12:317A, 2001) [39, 40] inaverage transport developed negative net ultrafiltration
within the 4 to 6 hour range with 1.5% dextrose, whereas whom the use of 2.5% dextrose solution for the long
dwell is associated with negative net ultrafiltration inthose with low or low average did so in the 8 to 12 hour
range. This implies that in high and average transport 25% of CAPD patients and 75% in APD patients.
The use of 4.25% dextrose leads to a very high peakpatients, negative net ultrafiltration will be a common
occurrence with the use of 1.5% dextrose solutions for in net ultrafiltration (and consequently a high intraperi-
toneal volume; Fig. 6). The early phase of positive netthe long dwell.
The findings with 2.5% dextrose are presented in Fig- ultrafiltration is accentuated and the increase in intra-
peritoneal volume is exaggerated. This corresponds wellure 5. The peak net UF observed was expectedly higher
than that observed with 1.5% dextrose, but the same to the clinical observation of high reports of discomfort
in patients using this high tonicity of dextrose-based solu-biphasic pattern of response, and the greater divergence
of the groups beyond the time frame of the usual PET tion, particularly if the original dwell volume is high. The
high peak intraperitoneal volume achieved contributesare illustrated. The higher tonicity leads to a shift of the
time to expected negative net UF to the 8 to 12 hour to the attenuated latter phase. An additional factor re-
sponsible for this attenuation is the delay in reachingrange for the high and high average transporters, a range
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standard PET allows for the establishment of a
test standard more representative than previous
smaller studies. We recommend that our profiling
be used as a reference description.
(2.) We have characterized the limited predictive value
of the current PET transport categories for the
ultrafiltration response during the short dwell.
(3.) Our computer modeling of UF profiles, however,
suggests that PET transport categories are useful
for prediction of transport profiles during the long
dwell. Further, our graphs allow clinical predictions
of therapeutic response and failure during the
long dwell that are similar to those observed clini-Fig. 8. Temporal profile of net ultrafiltration in high average transport
patients with the use of () 1.5%, () 2.5%, () 4.25% dextrose or cally, and hence can be used for therapy planning.
() 7.5% icodextrin solutions.
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